Sponsored Links

Patients With Early-Stage Chronic Kidney Disease And Elevated Levels Of Certain Hormone More Likely To Experience Poorer Outcomes PDF Print E-mail
Medical News - Endocrinology
Patients in the early stages of chronic kidney disease who had elevated levels of the endocrine hormone fibroblast growth factor 23 (that regulates phosphorus metabolism) had an associated increased risk of end-stage renal disease and death, according to a study in the June 15 issue of JAMA...

Read more: Endocrinology News From Medical News Today